Point72 Asset Management
IMCR icon

Point72 Asset Management’s Immunocore IMCR Stock Holding History

Point72 Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2M Buy
1,102,271
+598,120
+119% +$19.3M 0.04% 555
2025
Q4 		$17.5M Sell
504,151
-31,680
-6% -$1.12M 0.02% 986
2025
Q3 		$19.5M Sell
535,831
-284,594
-35% -$9.67M 0.03% 560
2025
Q2 		$25.7M Buy
820,425
+192,133
+31% +$5.97M 0.05% 418
2025
Q1 		$18.6M Buy
628,292
+224,988
+56% +$6.75M 0.04% 462
2024
Q4 		$11.9M Buy
+403,304
New +$12.8M 0.03% 637
2022
Q2 		– Sell
-407,058
Closed -$12.2M – 1500
2022
Q1 		$12.2M Buy
407,058
+394,658
+3,183% +$9.96M 0.05% 460
2021
Q4 		$425K Sell
12,400
-136,600
-92% -$4.95M ﹤0.01% 980
2021
Q3 		$5.52M Buy
149,000
+76,100
+104% +$2.57M 0.02% 641
2021
Q2 		$2.85M Buy
+72,900
New +$2.81M 0.01% 691

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Point72 Asset Management's IMCR Position: Q1 2026 in Review

Point72 Asset Management increased its Immunocore (IMCR) stake by 119% in Q1 2026, buying an estimated $19.3M and bringing the position to 1,102,271 shares worth $33.2M. The position accounts for 0.04% of the portfolio, ranked #555.

Point72 Asset Management first reported a position in IMCR in Q2 2021 and has held it in 10 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Point72 Asset Management held 1,102,271 shares of Immunocore worth $33.2M as of Q1 2026.
  • Point72 Asset Management bought 598,120 Immunocore shares in Q1 2026, an estimated $19.3M.
  • Immunocore made up 0.04% of Point72 Asset Management's portfolio in Q1 2026, its #555 holding.
  • Point72 Asset Management first reported a position in Immunocore in Q2 2021 and has held it in 10 quarters since.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.